Borislava Ananieva
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)

Marko Korenjak is the President of the European Liver Patient Association (ELPA), representing 39 liver patient associations from 29 countries in the WHO European region. He serves as a Civil Society Representative on the Management Board of the European Medicines Agency (EMA). Previously, he was a member of EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) and co-chair of the Patient and Consumer Working Party (PCWP). He also served on the DIA Advisory Council for Europe, Middle East & Africa (ACEMEA) and remains active in the WHO EURO Collaborating Committee on TB, HIV, and viral hepatitis, as well as in the EU working group on monitoring hepatitis B and C. Marko is a member of the HERA Civil Society Advisory Forum. He holds three Master’s degrees—in Business and Economy, International Relations and Diplomacy, and International Patient Advocacy. At ELPA, he leads a team involved in 20 EU Horizon projects, managing over 200 million EUR in liver-related research with more than 180 partner organizations. In 2017, The Economist’s Research Unit named him one of the 18 most influential individuals in hepatitis elimination. In 2024, he received the "Made with Patients" award from PFMD, the world’s highest recognition for patient engagement.
Capacity Building Officer & Patient Advocate, European Patients' Forum (EPF)
President, European Federation of Neurological Associations (EFNA)
President, Standing Committee of European Doctors (CPME)
Secretary General, European Alcohol Policy Alliance
President & CEO, The Ehlers-Danlos Society
Director of Preference Research and Global Lead of the Patient-Centered Outcomes, OPEN Health
MD, Board Member, European Patients' Forum (EPF)
Senior Manager IVD, MedTech Europe
Executive Director, European Regional and Local Health Authorities (EUREGHA)
Researcher & Populariser, Vaccination et Lien Social (VLS)
Senior Research Officer, Swedish Research Council
Chair, Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
Executive Director, EUPATI
Movement Health, Executive Director
Deputy Administrator General, National Institute for Health and Disability Insurance (NIHDI)
President, European Patients' Forum (EPF)
Director for Executive Education in Government, Health and Non Profit Division, SDA Bocconi
Implementation Scientist & Qualitative Researcher, University of Antwerp
Policy Officer, DG SANTE, European Commission
President, European Liver Patient Association (ELPA)
Head of Government Affairs, EMEA MedTech, Johnson & Johnson
Professor, Sorbonne Université
Regional Director, WHO/Europe
Youth Group Member, European Patients' Forum (EPF)
Director for Digital, EU4Health and Health systems modernisation, DG SANTE, European Commission
IMMUcan scientific lead
Senior Economist, Organisation for Economic Co-operation and Development (OECD)
Executive Director, Biomed Alliance
SVP International, Butterfly Network Inc
Director General, AESGP
Vice President Corporate Affairs, Shionogi Europe
Public Affairs Director, OM Pharma
Chief Medical Officer, European Medicines Agency
Prof Dr, Erasmus University Rotterdam
Head of Unit, Policy and Coordination, HERA, European Commission
More speakers Announced soon
Stay Tuned!
CEO, Millwater Partners
Chief Partnership Officer, The Synergist
Policy Officer, European Patients' Forum (EPF)
Policy Officer, European Patients' Forum (EPF)
Head of Policy, European Patients' Forum (EPF)
Interim Executive Director, European Patients' Forum (EPF)
More moderators Announced soon
Stay Tuned!